Theratechnologies Inc T.TH

Cedars Sinai has now started recruiting!

[scarlet1967]

• Study No.
  TH1902-CTR-001
• Principal Investigator
  Mita, Monica
• Phase
  I
• Study Name
  TH1902-CTR-001:A Phase 1, Open-Label, Dose Escalation Study of TH1902 in Patients with Advanced Solid Tumors and Expansion in Patients with Triple Negative Breast Cancer (TNBC), Gynecological Cancer, Colorectal Cancer, and Pancreatic Cancer (IRB#1343)
• Cancer Type
  Anus; Breast; Cervix; Colon; Corpus Uteri; Esophagus; Eye and Orbit; Kidney; Larynx; Lip, Oral Cavity and Pharynx; Liver; Ovary; Pancreas; Prostate; Rectum; Small Intestine; Stomach; Thyroid; Urinary Bladder

 

Protocol Summary

[scarlet1967]

The professor in charge... “Specialty IM/Hematology/Oncology Research Profile The research of Monica Mita, MD, focuses on the phase I clinical trials in oncology, novel drugs and targeted therapies. Education Medical School: Carol Davila University, Romania, 1992 Fellowship: University of Texas Health Science Center, 2005 Fellowship: Cancer Therapy and Research Center

[palinc2000]

Can anyone describe the the process in sites selection...who picks the sites,?are recruiting sites basing their decision to participate purely on cash for their services ? or can it be considered as an expression of confidence in the science.....

[SPCEO1]

So, it appears that both Mary Crowley and Cedars Sinai are up and running now. Clinicaltrials.gov still do not acknowledge that but that is not surprising as the website is typically updated only sporadically. Now, we need to see some additional centers added to the list and we shoiu,d also see some European cancer test sites open but likely not until July as it takes longer to get going there. I

[Bucknelly21]

Is it that surprising that thtx gave us half the info? Lol

[qwerty22]

I was going on the resumption that the cancer type was probably just a box ticking process on a form and that they get the longer list of cancer types based on the 1a all-comer criteria.